Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 2
2007 1
2008 1
2009 3
2010 3
2012 2
2013 3
2014 5
2015 3
2016 5
2017 3
2018 6
2019 3
2020 3
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Results by year
Filters applied: . Clear all
Page 1
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma.
Saltarella I, Desantis V, Melaccio A, Solimando AG, Lamanuzzi A, Ria R, Storlazzi CT, Mariggiò MA, Vacca A, Frassanito MA. Saltarella I, et al. Among authors: frassanito ma. Cells. 2020 Jan 9;9(1):167. doi: 10.3390/cells9010167. Cells. 2020. PMID: 31936617 Free PMC article. Review.
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment.
Solimando AG, Da Vià MC, Cicco S, Leone P, Di Lernia G, Giannico D, Desantis V, Frassanito MA, Morizio A, Delgado Tascon J, Melaccio A, Saltarella I, Ranieri G, Ria R, Rasche L, Kortüm KM, Beilhack A, Racanelli V, Vacca A, Einsele H. Solimando AG, et al. Among authors: frassanito ma. J Clin Med. 2019 Jul 9;8(7):997. doi: 10.3390/jcm8070997. J Clin Med. 2019. PMID: 31323969 Free PMC article. Review.
MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance.
Desantis V, Saltarella I, Lamanuzzi A, Melaccio A, Solimando AG, Mariggiò MA, Racanelli V, Paradiso A, Vacca A, Frassanito MA. Desantis V, et al. Among authors: frassanito ma. Int J Mol Sci. 2020 Apr 27;21(9):3084. doi: 10.3390/ijms21093084. Int J Mol Sci. 2020. PMID: 32349317 Free PMC article. Review.
Microenvironment drug resistance in multiple myeloma: emerging new players.
Di Marzo L, Desantis V, Solimando AG, Ruggieri S, Annese T, Nico B, Fumarulo R, Vacca A, Frassanito MA. Di Marzo L, et al. Among authors: frassanito ma. Oncotarget. 2016 Sep 13;7(37):60698-60711. doi: 10.18632/oncotarget.10849. Oncotarget. 2016. PMID: 27474171 Free PMC article. Review.
BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic features.
Tolomeo D, Agostini A, Macchia G, L'Abbate A, Severgnini M, Cifola I, Frassanito MA, Racanelli V, Solimando AG, Haglund F, Mertens F, Storlazzi CT. Tolomeo D, et al. Among authors: frassanito ma. Hum Cell. 2021 Jan;34(1):238-245. doi: 10.1007/s13577-020-00418-7. Epub 2020 Aug 27. Hum Cell. 2021. PMID: 32856169
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
Frassanito MA, Desantis V, Di Marzo L, Craparotta I, Beltrame L, Marchini S, Annese T, Visino F, Arciuli M, Saltarella I, Lamanuzzi A, Solimando AG, Nico B, De Angelis M, Racanelli V, Mariggiò MA, Chiacchio R, Pizzuti M, Gallone A, Fumarulo R, D'Incalci M, Vacca A. Frassanito MA, et al. J Pathol. 2019 Feb;247(2):241-253. doi: 10.1002/path.5187. J Pathol. 2019. PMID: 30357841
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma.
Desantis V, Frassanito MA, Tamma R, Saltarella I, Di Marzo L, Lamanuzzi A, Solimando AG, Ruggieri S, Annese T, Nico B, Vacca A, Ribatti D. Desantis V, et al. Among authors: frassanito ma. Ann Hematol. 2018 Jul;97(7):1251-1258. doi: 10.1007/s00277-018-3293-x. Epub 2018 Mar 28. Ann Hematol. 2018. PMID: 29589107
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma.
Lamanuzzi A, Saltarella I, Desantis V, Frassanito MA, Leone P, Racanelli V, Nico B, Ribatti D, Ditonno P, Prete M, Solimando AG, Dammacco F, Vacca A, Ria R. Lamanuzzi A, et al. Among authors: frassanito ma. Oncotarget. 2018 Apr 17;9(29):20563-20577. doi: 10.18632/oncotarget.25003. eCollection 2018 Apr 17. Oncotarget. 2018. PMID: 29755672 Free PMC article.
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study.
Rao L, De Veirman K, Giannico D, Saltarella I, Desantis V, Frassanito MA, Solimando AG, Ribatti D, Prete M, Harstrick A, Fiedler U, De Raeve H, Racanelli V, Vanderkerken K, Vacca A. Rao L, et al. Among authors: frassanito ma. Oncotarget. 2018 Jan 30;9(17):13366-13381. doi: 10.18632/oncotarget.24351. eCollection 2018 Mar 2. Oncotarget. 2018. PMID: 29568363 Free PMC article.
Treg lymphocytes in autoimmune uveitis.
Ruggieri S, Frassanito MA, Dammacco R, Guerriero S. Ruggieri S, et al. Among authors: frassanito ma. Ocul Immunol Inflamm. 2012 Aug;20(4):255-61. doi: 10.3109/09273948.2012.681830. Epub 2012 May 7. Ocul Immunol Inflamm. 2012. PMID: 22564107
38 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page